Literature DB >> 14803639

Characteristics of the multiplication cycle of pneumonia virus of mice (PVM).

H S GINSBERG, F L HORSFALL.   

Abstract

A study of the multiplication of PVM in the mouse lung yielded evidence in support of the hypothesis that discrete cycles occur. The cycle is characterized by a latent period of about 15 hours, an incremental period of 10 to 15 hours and a total duration of 24 to 30 hours. The yield of virus per cycle is approximately 16-fold. A large proportion, approximately 90 per cent, of PVM is lost on intranasal inoculation and cannot be recovered from the lung. Of the virus which reaches the lung, almost all becomes non-infective within 12 hours even though a considerable amount retains the capacity to cause hemagglutination. During the incremental period infective virus appears as soon as any increase in hemagglutination is demonstrable.

Entities:  

Keywords:  PNEUMONIA, VIRAL; VIRUSES

Mesh:

Year:  1951        PMID: 14803639      PMCID: PMC2136057          DOI: 10.1084/jem.93.2.151

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  The dependence of the pathological lesion upon the multiplication of pneumonia virus of mice (PVM); kinetic relation between the degree of viral multiplication and the extent of pneumonia.

Authors:  F L HORSFALL; H S GINSBERG
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

2.  THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM).

Authors:  F L Horsfall; M McCarty
Journal:  J Exp Med       Date:  1947-05-31       Impact factor: 14.307

3.  Further studies on the associative reactions of pneumonia virus of mice and influenza viruses; combination with various animal tissues and adsorbents.

Authors:  F M DAVENPORT; F L HORSFALL
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

4.  Studies on host-virus interactions in the chick embryo-influenza virus system; development of infectivity, hemagglutination, and complement fixation activities during the first infectious cycle.

Authors:  W HENLE; G HENLE
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

5.  STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : III. HEMAGGLUTINATION BY THE VIRUS; THE OCCURRENCE OF COMBINATION BETWEEN THE VIRUS AND A TISSUE SUBSTANCE.

Authors:  E C Curnen; F L Horsfall
Journal:  J Exp Med       Date:  1946-01-31       Impact factor: 14.307

6.  A LATENT VIRUS IN NORMAL MICE CAPABLE OF PRODUCING PNEUMONIA IN ITS NATURAL HOST.

Authors:  F L Horsfall; R G Hahn
Journal:  J Exp Med       Date:  1940-02-29       Impact factor: 14.307

7.  STUDIES ON A LUNG TISSUE COMPONENT WHICH COMBINES WITH PNEUMONIA VIRUS OF MICE (PVM).

Authors:  M Volkert; F L Horsfall
Journal:  J Exp Med       Date:  1947-10-31       Impact factor: 14.307

8.  STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : I. THE PRECISION OF MEASUREMENTS IN VIVO OF THE VIRUS AND ANTIBODIES AGAINST IT.

Authors:  F L Horsfall; E C Curnen
Journal:  J Exp Med       Date:  1946-01-01       Impact factor: 14.307

9.  A resistant variant of mumps virus; multiplication of the variant in the presence of inhibitory quantities of Friedländer bacillus polysaccharide.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

10.  THE DEMONSTRATION OF ONE-STEP GROWTH CURVES OF INFLUENZA VIRUSES THROUGH THE BLOCKING EFFECT OF IRRADIATED VIRUS ON FURTHER INFECTION.

Authors:  W Henle; G Henle; E B Rosenberg
Journal:  J Exp Med       Date:  1947-10-31       Impact factor: 14.307

View more
  13 in total

1.  Characteristics on the adenoviruses. III. Reproductive cycle of types 1 to 4.

Authors:  H S GINSBERG
Journal:  J Exp Med       Date:  1958-01-01       Impact factor: 14.307

2.  Observations on the mode of multiplication of herpes virus.

Authors:  S P BEDSON; J V GOSTLING
Journal:  Br J Exp Pathol       Date:  1956-10

3.  The mode of virus multiplication and the susceptibility of these agents to the antibiotics.

Authors:  S P BEDSON
Journal:  J Clin Pathol       Date:  1956-05       Impact factor: 3.411

4.  Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.

Authors:  John A Ellis; Brittany V Martin; Cheryl Waldner; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Vaccine       Date:  2006-10-12       Impact factor: 3.641

5.  Reproduction of influenza viruses; quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction.

Authors:  F L HORSFALL
Journal:  J Exp Med       Date:  1955-10-01       Impact factor: 14.307

6.  Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

7.  Studies on the psittacosis-lymphogranuloma group. II. A non-infectious phase in virus development following adsorption to host tissue.

Authors:  A J GIRARDI; E G ALLEN; M M SIGEL
Journal:  J Exp Med       Date:  1952-09       Impact factor: 14.307

8.  Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo.

Authors:  Cynthia A Bonville; Caroline M Percopo; Kimberly D Dyer; Jiliang Gao; Calman Prussin; Barbara Foster; Helene F Rosenberg; Joseph B Domachowske
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

9.  Efficient replication of pneumonia virus of mice (PVM) in a mouse macrophage cell line.

Authors:  Kimberly D Dyer; Ingrid Mm Schellens; Cynthia A Bonville; Brittany V Martin; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virol J       Date:  2007-06-04       Impact factor: 4.099

10.  Effect of sodium monofluoroacetate on the multiplication of influenza viruses, mumps virus and pneumonia virus of mice (PVM).

Authors:  W J MOGABGAB; F L HORSFALL
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.